Herborium Group, Inc.

HBRM

US42703A2087

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 16:42:40 17/05/2024 BST			5-day change	1st Jan Change
0.0001 ^USD	0.00%		0.00%	+9,900.00%

2021	Herborium Group, Inc. Moves into Manufacturing Phase for Its New Protein Bars	CI
2021	Herborium Group Progresses with Distribution Agreements for Acnease and Cosmeceuticals to Take Advantage of $8 Billion French Cosmetic Market	CI

Herborium Group, Inc. will Change its Ticker to HBRM from HBRM.D

February 25, 2014 at 05:00 am

Effective February 25, 2014, Herborium Group, Inc. will change its Pink Sheets LLC stock ticker symbol to HBRM from HBRM.D.

Latest news about Herborium Group, Inc.

Herborium Group, Inc. Moves into Manufacturing Phase for Its New Protein Bars	07/10/21	CI
Herborium Group Progresses with Distribution Agreements for Acnease and Cosmeceuticals to Take Advantage of $8 Billion French Cosmetic Market	21/09/21	CI
Herborium to Develop Proprietary Protein Bar with Unique Skin Benefits and Weight Management Properties	28/06/21	CI
Herborium Group, Inc. Announces Joining of Ashok N. Vasvani to Herborium Team	23/06/21	CI
Herborium Group, Inc. Moves to the Next Level in Building Disruptive, Integrated, Natural Medicine Content and Commerce Platform	23/03/21	CI
Herborium Group, Inc. Announces Unique Herbal Acne Treatment AcnEase to Enter the Fastest Growing Asia Pacific Market	04/03/21	CI
Herborium Group, Inc. Introduces Proprietary Two- In- One Biodegradable, Multi-Use Facial Mask	08/02/21	CI
Herborium Group, Inc. Reports Sales Results for the Second Quarter and Six Months of 2015	25/06/15	CI
Herborium Group, Inc. Announces Earnings Results for the First Quarter of 2015	16/04/15	CI
Herborium Group, Inc. Announces Sales Results for the First Quarter of Fiscal 2015	31/03/15	CI
Herborium Group, Inc. Announces Earnings Results for the Full Year 2014	02/03/15	CI
Herborium(R) Group, Inc. Announces Earnings Results for the Third Quarter of 2014 and Sales Results for the First Three Quarters of 2014	16/10/14	CI
Herborium Group, Inc. Reports Sales Results for the Second Quarter and Six Months Ended May 31, 2014	17/07/14	CI
Herborium Group, Inc. Reports Sales Results for the First Quarter of 2014	27/03/14	CI
Herborium Group, Inc. Announces Sales Results for the Year 2013	10/03/14	CI
Herborium Group, Inc. will Change its Ticker to HBRM from HBRM.D	25/02/14	CI
Herborium Group, Inc. will Change its Ticker to HBRMD from HBRM.D	27/01/14	CI
Herborium Seeks Acquisitions	27/01/14	CI
Herborium Group, Inc. Launches Two New Botanical Therapeutics(R): Lasting Pleasure(R) for Women and Lasting Power(R) for Men	26/11/13	CI
Tranche Update on Herborium Group, Inc.'s Equity Buyback Plan announced on April 23, 2012	14/04/13	CI
Tranche Update on Herborium Group, Inc.'s Equity Buyback Plan announced on April 23, 2012	27/02/13	CI
China Health Resource, Inc. cancelled the acquisition of Herborium Group Inc (OTC PINKSHEETS:HBRM) on February 21, 2013.	21/02/13	CI
Herborium Group, Inc. Completes Manufacturing of Sexual Health Formulas to Hit the Market in March 2013	14/02/13	CI
Herborium Group, Inc. Revised Revenue Guidance for 2013	29/01/13	CI
Herborium Group, Inc.'s Equity Buyback announced on April 23, 2012 has expired with the repurchase of 0 shares, representing 0% for $0 million.	31/12/12	CI

Herborium Group, Inc. is a developer, licensor and marketer of herbal ingredient-based medicines and wellness products. The Company's flagship product, AcnEase is an herbal, oral treatment for patients with acne or rosacea. The Company serves clients worldwide. It is engaged in the development of a series of the artificial intelligence (AI)-based content products related to dermatological and beauty space. In addition to AcnEase, the Company has secured a pipeline of product candidates. The products include protein skin bar and adjunct cutting age skincare products based on stem cell technology. it is also ready for commercialization of new products line of natural sexual health and performance enhancing products for men and women. The Company owns all formulations for its proprietary products.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
HERBORIUM GROUP, INC.	+9,900.00%	1.09M
VERTEX PHARMACEUTICALS INCORPORATED	+9.42%	114B
REGENERON PHARMACEUTICALS, INC.	+11.84%	104B
BIONTECH SE	-14.15%	22.41B
ARGENX SE	-1.05%	22.28B
GENMAB A/S	-5.29%	19.07B
WUXI APPTEC CO., LTD.	-38.29%	18B
BEIGENE, LTD.	-4.16%	17.89B
NEUROCRINE BIOSCIENCES, INC.	+7.99%	14.28B
SAREPTA THERAPEUTICS, INC.	+36.24%	12.55B

Bio Therapeutic Drugs